Skip to main content
    I

    Innoviva Inc (INVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $20.74
    -0.71 (-3.31%)

    Market Cap: $1.50B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    49%(19/39)
    Avg Surprise
    +208.47%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.34
    Range$-0.36 - $0.57
    5 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.38-10.5%
    60d ago$0.38-10.5%
    30d ago$0.25+38.2%
    7d ago$0.25+38.2%
    Current$0.34
    Revenue Consensus
    $115M
    Range$104M - $133M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.96
    Range$0.22 - $1.29
    5 analysts
    Revenue Consensus
    $124M
    Range$94M - $164M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.96---
    Sep 26EST
    		-$0.34---
    Jun 26
    Reported Aug 5
    		$0.59$0.56+5.36%Beat-23.4%
    Mar 26
    Reported May 6
    		$0.47$0.43+9.30%Beat+163.3%
    Dec 25
    Reported Feb 25
    		$1.94$0.57+238.68%Beat+647.7%
    Sep 25
    Reported Nov 5
    		$1.08$0.46+134.78%Beat+800.0%
    Jun 25
    Reported Aug 6
    		$0.77$0.50+54.00%Beat+240.0%
    Mar 25
    Reported May 7
    		$-0.74$0.33-325.12%Miss-261.5%
    Dec 24
    Reported Feb 26
    		$0.26$0.41-36.59%Miss-65.8%
    Sep 24
    Reported Nov 6
    		$0.12N/A-55.56%Miss-33.3%
    Jun 24
    Reported Jul 31
    		$-0.55$0.24-329.17%Miss-2850.0%
    Mar 24
    Reported May 8
    		$0.46$0.17+170.59%Beat+9.5%
    Dec 23
    Reported Feb 29
    		$0.76$0.23+230.43%Beat+177.6%
    Sep 23
    Reported Nov 1
    		$0.18$0.27-33.33%Miss-66.7%
    Jun 23
    Reported Aug 2
    		$0.02N/A-92.31%Miss-96.8%
    Mar 23
    Reported May 9
    		$0.42$0.23+82.61%Beat-4.5%
    Dec 22
    Reported Feb 28
    		$-0.98$0.23-526.09%Miss-800.0%
    Sep 22
    Reported Nov 9
    		$0.54N/A-75.89%Miss-40.0%
    Jun 22
    Reported Jul 27
    		$0.62$0.44+40.91%Beat-31.1%
    Mar 22
    Reported Apr 27
    		$0.44$0.48-8.33%Miss-47.6%
    Dec 21
    Reported Feb 9
    		$0.14N/A-65.85%Miss-74.5%
    Sep 21
    Reported Oct 27
    		$0.90$0.43+109.30%Beat+95.7%
    Jun 21
    Reported Jul 28
    		$0.90$0.29+210.34%Beat+172.7%
    Mar 21
    Reported Apr 28
    		$0.84$-0.01+8500.00%Beat+100.0%
    Dec 20
    Reported Feb 3
    		$0.55$0.40+37.50%Beat+31.0%
    Sep 20
    Reported Oct 28
    		$0.46$0.42+9.52%Beat+27.8%
    Jun 20
    Reported Jul 29
    		$0.33$0.32+3.13%Beat-2.9%
    Mar 20
    Reported Apr 29
    		$0.42$0.36+16.67%Beat+35.5%
    Dec 19
    Reported Feb 5
    		$0.42$0.50-16.00%Miss-30.0%
    Sep 19
    Reported Oct 30
    		$0.36$0.37-2.70%Miss-18.2%
    Jun 19
    Reported Jul 24
    		$0.34$0.42-19.05%Miss-30.6%
    Mar 19
    Reported May 1
    		$0.31$0.36-13.89%Miss+14.8%
    Dec 18
    Reported Feb 6
    		$0.60$0.65-7.69%Miss+25.0%
    Sep 18
    Reported Oct 31
    		$0.44$0.42+4.76%Beat+57.1%
    Jun 18
    Reported Jul 26
    		$0.49$0.55-10.91%Miss+63.3%
    Mar 18
    Reported Apr 26
    		$0.27$0.53-49.06%Miss+80.0%
    Dec 17
    Reported Feb 8
    		$0.48$0.49-2.04%Miss+118.2%
    Sep 17
    Reported Oct 25
    		$0.28$0.33-15.15%Miss-
    Jun 17
    Reported Jul 26
    		$0.30$0.29+3.45%Beat-
    Mar 17
    Reported Apr 27
    		$0.15$0.28-46.43%Miss-
    Dec 16
    Reported Feb 9
    		$0.22$0.22+0.00%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio5.08EV/EBITDA4.30x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin81.20%Operating Margin43.30%
    ROE36.70%ROIC13.69%
    Financial Health
    Debt/Equity0.21xInterest Coverage13.15x
    Current Ratio16.01xQuick Ratio15.18x
    Trading Statistics
    Beta0.38Avg Volume1.00M
    52-Week High$25.1452-Week Low$17.10

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$20.91
    SMA 20$20.92
    SMA 50$20.96
    SMA 200$21.80
    EMA 10$20.97
    EMA 20$20.95
    EMA 50$21.10
    EMA 200$21.34

    MACD

    Line: -0.01Signal: -0.04Hist: 0.04

    ADX

    ADX: 9.2+DI: 22.0-DI: 20.9

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down44.0
    PSAR$20.45

    Bollinger Bands

    Upper Band$21.53
    Lower Band$20.31
    %B Position582%(Upper)
    Band Width0.35

    RSI (14-Day)

    Neutral
    46.8

    Momentum Oscillators

    Stoch %K71.4
    Stoch %D71.7
    Williams %R-63.8
    ROC (10d)-1.8%
    Momentum-0.37
    CCI (20d)20.1
    MFI (14d)54.2

    Volatility Measures

    ATR (14d)$0.48(2.3%)
    StdDev (20d)0.30
    Hist Vol27.0%(Moderate)

    Volume Flow

    VWAP$21.00
    OBV10.5M
    AD Line-12.7M
    CMF (20d)-0.174

    Volume Metrics

    Avg Vol (20d)1.0M
    Vol Ratio0.8x
    VWMA (20d)$20.80

    Pivot Points

    R3$21.94
    R2$21.71
    R1$21.58
    Pivot Point$21.35
    S1$21.22
    S2$20.99
    S3$20.86

    Advanced Oscillators

    TSI-0.48
    Ultimate Osc53.3
    KST-5.70

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$119.59M$97.99M$114.61M$107.80M$100.28M$88.63M$91.81M$89.51M$99.90M$77.50M$85.84M$67.26M
    Cost of Revenue$28.98M$22.16M$38.95M$32.26M$17.14M$15.32M$13.68M$16.50M$14.91M$17.41M$34.91M$10.18M
    Gross Profit$90.62M$75.83M$75.67M$75.54M$83.15M$73.31M$78.13M$73.01M$84.99M$60.09M$50.93M$57.08M
    Operating Expenses$39.76M$37.68M$36.68M$40.96M$34.40M$31.89M$34.99M$29.77M$30.30M$34.28M$76.40M$-30,204,000
    R&D$5.19M$5.24M$4.55M$13.67M$7.98M$4.40M$3.67M$3.55M$2.56M$3.88M$2.36M$3.99M
    SG&A$34.57M$32.44M$32.12M$27.29M$26.41M$27.49M$31.33M$26.22M$27.74M$30.41M$26.32M$28.64M
    Operating Income$50.85M$38.15M$38.99M$34.58M$48.75M$41.43M$43.14M$43.24M$54.69M$25.80M$-25,474,000$87.28M
    Interest Income$-124,235,000$168.64M$117.30M$36.22M$18.01M$-9,011,000$-15,488,000$-12,731,000$-56,634,000$39.74M$82.18M$4.11M
    Interest Expense$5.47M$5.44M$3.31M$4.01M$4.66M$4.71M$4.75M$5.81M$5.80M$5.85M$5.95M$4.40M
    Income Before Tax$-108,020,000$234.56M$195.04M$97.82M$72.60M$-38,589,000$24.69M$6.85M$-39,279,000$45.12M$61.20M$85.95M
    Income Tax Expense$-24,600,000$47.97M$30.88M$7.91M$8.91M$8.00M$4.36M$5.64M$-4,594,000$8.59M$-330,000$3.91M
    Net Income$-83,420,000$186.59M$164.15M$89.91M$63.69M$-46,584,000$20.33M$1.21M$-34,685,000$36.53M$61.53M$82.05M
    EBITDA$32.20M$81.77M$91.52M$76.17M$69.83M$-14,363,000$55.46M$35.91M$33.60M$21.71M$-4,515,000$96.75M
    EBIT$21.69M$71.36M$81.05M$65.61M$59.25M$-24,867,000$44.93M$25.39M$23.16M$11.23M$-15,025,000$86.23M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INVA

    INVA Valuation and Fair Value

    P/E
    5.1x
    Forward P/E
    8.5x
    EV/EBITDA
    4.3x
    PEG
    0.3x
    P/B
    1.2x
    See GNG's fair value

    INVA Profitability: Margins, ROIC and FCF

    Gross margin
    72.2%
    Operating margin
    43.3%
    Net margin
    81.2%
    ROIC
    13.7%
    ROE
    36.7%
    FCF margin
    43.1%

    INVA Competitors

    CompanyTicker
    Stoke Therapeutics IncSTOK
    UltragenyxRARE
    Eton Pharmaceuticals IncETON
    Certara IncCERT
    Phibro Animal Health CorporationPAHC
    Immunocore Holdings LtdIMCR
    Structure Therapeutics Inc. American Depositary SharesGPCR
    Uniqure NVQURE

    Sector: Healthcare

    INVA Analyst Ratings

    Consensus
    Hold
    Analysts
    4
    Strong Buy
    0
    Buy
    3
    Hold
    0
    Sell
    1
    Strong Sell
    0

    INVA Bull Case vs Bear Case

    Bull case

    • INVA converts 43.1% of revenue into free cash flow.
    • INVA has an 81.2% net profit margin.
    • INVA grew quarterly revenue 19.3% year over year.

    INVA Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    3.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.34
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    INVA Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    Frequently Asked Questions About INVA

    Does INVA pay dividends?

    Innoviva Inc (INVA) has a dividend payment track record. See the INVA dividend history page for its current payment status, TTM yield, and recorded payments.

    What is INVA's P/E ratio?

    Innoviva Inc has a price-to-earnings (P/E) ratio of 5.08.

    What is INVA's market cap?

    Innoviva Inc (INVA) has a market capitalization of $1.50B with a current stock price of $20.74.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In